Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Immunology of age-related macular degeneration.

Ambati J, Atkinson JP, Gelfand BD.

Nat Rev Immunol. 2013 Jun;13(6):438-51. doi: 10.1038/nri3459. Review.

2.

Age-related macular degeneration: Complement in action.

van Lookeren Campagne M, Strauss EC, Yaspan BL.

Immunobiology. 2016 Jun;221(6):733-9. doi: 10.1016/j.imbio.2015.11.007. Epub 2015 Dec 19. Review.

3.

Age-related macular degeneration.

Khandhadia S, Cherry J, Lotery AJ.

Adv Exp Med Biol. 2012;724:15-36. doi: 10.1007/978-1-4614-0653-2_2. Review.

PMID:
22411231
4.

Age-related macular degeneration: an immunologically driven disease.

Nussenblatt RB, Liu B, Li Z.

Curr Opin Investig Drugs. 2009 May;10(5):434-42. Review.

PMID:
19431076
5.

[The complement system and its possible role in the pathogenesis of age-related macular degeneration (AMD)].

Charbel Issa P, Scholl HP, Holz FG, Knolle P, Kurts C.

Ophthalmologe. 2005 Nov;102(11):1036-42. Review. German.

PMID:
16215754
6.

Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.

Kawa MP, Machalinska A, Roginska D, Machalinski B.

J Immunol Res. 2014;2014:483960. doi: 10.1155/2014/483960. Epub 2014 Sep 4. Review.

7.

Genetics of immunological and inflammatory components in age-related macular degeneration.

Tuo J, Grob S, Zhang K, Chan CC.

Ocul Immunol Inflamm. 2012 Feb;20(1):27-36. doi: 10.3109/09273948.2011.628432. Review.

8.

The role of complement in AMD.

Zipfel PF, Lauer N, Skerka C.

Adv Exp Med Biol. 2010;703:9-24. doi: 10.1007/978-1-4419-5635-4_2. Review.

PMID:
20711704
9.

Inflammaging: should this term be suitable for age related macular degeneration too?

Gallenga CE, Parmeggiani F, Costagliola C, Sebastiani A, Gallenga PE.

Inflamm Res. 2014 Feb;63(2):105-7. doi: 10.1007/s00011-013-0684-2. Epub 2013 Nov 8.

PMID:
24202618
10.

Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.

Skerka C, Lauer N, Weinberger AA, Keilhauer CN, Sühnel J, Smith R, Schlötzer-Schrehardt U, Fritsche L, Heinen S, Hartmann A, Weber BH, Zipfel PF.

Mol Immunol. 2007 Jul;44(13):3398-406. Epub 2007 Mar 30.

PMID:
17399790
11.

Inflammation and age-related macular degeneration (AMD).

Telander DG.

Semin Ophthalmol. 2011 May;26(3):192-7. doi: 10.3109/08820538.2011.570849. Review.

PMID:
21609232
12.

Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.

Cheung CM, Wong TY.

J Intern Med. 2014 Aug;276(2):140-53. doi: 10.1111/joim.12227. Epub 2014 Mar 21. Review.

13.

Systemic complement activation in age-related macular degeneration.

Scholl HP, Charbel Issa P, Walier M, Janzer S, Pollok-Kopp B, Börncke F, Fritsche LG, Chong NV, Fimmers R, Wienker T, Holz FG, Weber BH, Oppermann M.

PLoS One. 2008 Jul 2;3(7):e2593. doi: 10.1371/journal.pone.0002593. Erratum in: PLoS ONE. 2008;3(7). doi: 10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad. PLoS ONE. 2008;3(7). doi: 10.1371/annotation/511a1029-bc43-4510-a4ca-c1db31810acc.

14.

Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.

Ristau T, Paun C, Ersoy L, Hahn M, Lechanteur Y, Hoyng C, de Jong EK, Daha MR, Kirchhof B, den Hollander AI, Fauser S.

PLoS One. 2014 Mar 27;9(3):e93459. doi: 10.1371/journal.pone.0093459. eCollection 2014.

15.

Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.

Merle BM, Silver RE, Rosner B, Seddon JM.

Am J Clin Nutr. 2015 Nov;102(5):1196-206. doi: 10.3945/ajcn.115.111047. Epub 2015 Oct 21.

16.

Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.

Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT.

JAMA. 2006 Jul 19;296(3):301-9.

PMID:
16849663
17.

Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.

Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V, Silvestri G, Chakravarthy U.

PLoS Med. 2007 Dec;4(12):e355.

18.

The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.

Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV.

Prog Retin Eye Res. 2010 Mar;29(2):95-112. doi: 10.1016/j.preteyeres.2009.11.003. Epub 2009 Dec 2. Review.

19.

Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.

Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML.

J Med Genet. 2009 May;46(5):300-7. doi: 10.1136/jmg.2008.062737. Epub 2008 Nov 17.

PMID:
19015224
20.

Age-related macular degeneration: genetic and clinical findings.

Kokotas H, Grigoriadou M, Petersen MB.

Clin Chem Lab Med. 2011 Apr;49(4):601-16. doi: 10.1515/CCLM.2011.091. Epub 2010 Dec 23. Review.

PMID:
21175380

Supplemental Content

Support Center